In this study, we recruited 105 GC patients and measured the concentration of 18 heavy metals, MSI status, and HER2 gene amplification through the methods of inductive coupled plasma emission spectrometry (ICP-MS), PCR, and fluorescence in situ hybridization (FISH), respectively. The gene discussed is ERBB2; the disease is gastric cancer.